The Physician as Medical Researcher

Less than a decade ago in this period of flourishing biomedical science, the contribution of physician-scientists to research was progressively declining to the point where the species seemed endangered. Although recent data from the National Institutes of Health suggest a reversal of this trend, the fact that the decline occurred at all has prompted me to think about the singular and perhaps critical role of the physician in research. The very origin of biomedical science owes much to the cont

Written byEdwin Kilbourne
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The very origin of biomedical science owes much to the contributions of physicians. Challenged by disease, physician-scientists such as Schwann, Golgi, Ludwig, Cohnheim, Bernard, Koch and Erlich developed the basic technology for the staining of diseased and normal tissues, the measurement of physiologic processes and the cultivation of bacteria. In so doing they opened the door not only to the scientific study of disease but also to the understanding of normal cell structure and function. The continuing potential of the physician for making fundamental contributions to science is evidenced by the Nobel Prizes in Physiology or Medicine, more than half of which have gone to physicians since 1970.

But the M.D. degree does not a scientist make. Indeed, some might say that the designation "physician-scientist," like "military intelligence," is a contradiction in terms. Physicians acquire a large number of scientific facts in the course of a medical education, and they ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies